<DOC>
	<DOCNO>NCT01279733</DOCNO>
	<brief_summary>The main objective multi-centered collaborative study evaluate accuracy , efficacy clinical advantage prenatal diagnosis use microarray analysis compare conventional karyotyping .</brief_summary>
	<brief_title>Prenatal Cytogenetic Diagnosis Array-Based Copy Number Analysis</brief_title>
	<detailed_description>Specifically , aim follow : 1 . Demonstrate performance microarray analysis clinical method prenatal cytogenetic diagnosis regard : 1 . Accuracy detection common autosomal sex chromosomal aneuploid ( trisomy , 13,18,21 , 45 , X , 47 , XXY , etc . ) 2 . Ability microarray diagnose less common , clinically significant , cytogenetic aneusomies ( e.g . DiGeorge , Williams , Smith- Magenis , Prader-Willi syndrome , etc . ) currently detect conventional karyotype . 3 . Evaluation utility microarray specific clinical scenario ultrasound detection congenital anomaly fetal growth disorder . 2 . Evaluate appropriate construction prenatal diagnostic microarray device allow maximal detection clinically relevant information minimal detection unexpected difficult interpret finding clinical significance might provoke patient anxiety . 3 . Evaluate feasibility cost-effectiveness use microarrays primary prenatal diagnostic tool . 4 . Evaluate approach integrate microarray clinical prenatal cytogenetic diagnostic practice . 5 . Develop prenatal diagnostic tissue repository ( TDR ) facilitate development microarray technology . This used investigate molecular etiology specific fetal anomaly test new technology , high resolution microarrays .</detailed_description>
	<criteria>1 . Singleton pregnancy either chorionic villus sample first trimester amniocentesis procedure 16 week gestation perform prenatal cytogenetic diagnosis 2 . Karyotyping perform Genzyme Genetics Cytogenetics Laboratory 3 . Trained study personnel available 4 . Presenting prespecified site use Genzyme Genetics routine prenatal diagnostic service 1 . Unavailability one biologic parent provide blood sample ( e.g . egg sperm donor , nonpaternity ) 2 . Patient refusal allow followup neonatal period age two select 3 . Participation study previous pregnancy 4 . Insufficient sample microarray assay</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>microarray</keyword>
</DOC>